WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7901 Infant (under 12 months) mortality rate: 592
GDP / capita (US$): 1'8501 Child (under 5 years) mortality rate: 912

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 12'576  12'231  11'882  11'531  11'177  6'701  5'768  4'705 
Births 447  440  431  423  414 
Surviving infants 417  409  400  391  382 
Pop. less than 5 years 1'966  1'925  1'882  1'846  1'809  1'194  1'047  847 
Pop. less than 15 years 5'241  5'122  5'001  4'888  4'771  3'004  2'553  2'093 
Female 15-49 years 3'007  2'916  2'825  2'729  2'633  1'508  1'323  1'081 

Number of reported cases

(Click for retrospective incidence data for South Sudan)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  487  898  878  441  525 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
  72  47 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  25 
Tetanus (total)**
ChartChart
  32 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for South Sudan)
Vaccine year result method % card seen                                                
BCG 2011  75  EPI   51  62  52  58  61  64 
DTP1 2011  79  EPI   51  77  58  60  72  60 
DTP3 2011  55  EPI   51  59  45  50  58  56 
DTP4         
IPV1          54  34 
HepB_BD         
HepB3          59  45  55 
Hib3          59  45  55 
JapEnc         
MCV1          75  51  70  52  55 
MCV2         
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2011  59  EPI   51  58  45  55  58  56 
Rota1         
RotaC         
RCV1         
TT2plus 2011  65  EPI   51  49  38  28  45  41 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for South Sudan)
BCG
ChartChart
  43  43  46  52 
DTP1
ChartChart
  37  37  49  57 
DTP3
ChartChart
  31  31  39  45 
HepB3
ChartChart
  31  31 
HepB_BD
ChartChart
 
Hib3
ChartChart
  31  31 
IPV1
 
MCV1
ChartChart
  20  20  22  30 
MCV2
 
PCV3
 
Pol3
ChartChart
  41  41  44  50 
RCV1
 
RotaC
 
YFV
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 80  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
81 
   
/
|
|
\
Greater or equal to 90% 25
From 80 to 89% 5
From 50 to 79% 19
Less than 50% 45
Proportion of districts
not reporting DTP3 coverage
6
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
TT First contact; +1, +6 months; +1, +1 year; Yes 15-49 years

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2018-2022  2'016  2012-2016  2012-2016  2012-2016  2012- 2016  2012 to 2016 
Nº of districts with microplans that include activities to raise immunization coverage number 60  80  43  43  80  80  79 

System performance

Total Nº districts in country number 80    80  80  80  80  79 
Nº districts with DTP3 coverage >=80% number 24  11  31  20  18  33  36 
% of districts with DTP3 coverage >=80% From 0 to 100% 30    39  25  23  41  46 
Nº districts with measles (MCV1) coverage >=95% number 25  20  28  27  36  45 
% of districts with MCV1 coverage >=95% From 0 to 100% 31    25  35  34  45  57 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes    No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No    No  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 11     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.